{"id":"https://openalex.org/W4361822847","doi":"https://doi.org/10.1158/0008-5472.c.6505829","title":"Data from CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy","display_name":"Data from CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4361822847","doi":"https://doi.org/10.1158/0008-5472.c.6505829"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6505829","doi":"https://doi.org/10.1158/0008-5472.c.6505829","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6505829","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.c.6505829","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055708371","display_name":"Yuting Ma","orcid":"https://orcid.org/0000-0001-6267-1852","observed_orcids":["https://orcid.org/0000-0001-6267-1852","https://orcid.org/0000-0002-0905-6639"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuting Ma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047030847","display_name":"Stephen R. Mattarollo","orcid":"https://orcid.org/0000-0003-3659-6507","observed_orcids":["https://orcid.org/0000-0003-3659-6507"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen R. Mattarollo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048555847","display_name":"Sandy Adjemian","orcid":"https://orcid.org/0000-0001-5594-5499","observed_orcids":["https://orcid.org/0000-0001-5594-5499"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandy Adjemian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013437001","display_name":"Heng Yang","orcid":"https://orcid.org/0000-0002-1491-4490","observed_orcids":["https://orcid.org/0000-0002-1491-4490"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heng Yang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091546512","display_name":"Laetitia Aymeric","orcid":"https://orcid.org/0000-0001-7459-7231","observed_orcids":["https://orcid.org/0000-0001-7459-7231"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laetitia Aymeric","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038255372","display_name":"Dalil Hannani","orcid":"https://orcid.org/0000-0001-5097-1401","observed_orcids":["https://orcid.org/0000-0001-5097-1401"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dalil Hannani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008056633","display_name":"Jo\u00e3o Paulo Portela Catani","orcid":"https://orcid.org/0000-0002-4866-3933","observed_orcids":["https://orcid.org/0000-0002-4866-3933"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jo\u00e3o Paulo Portela Catani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040640951","display_name":"Helene Duret","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helene Duret","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007330428","display_name":"Michele W.L. Teng","orcid":"https://orcid.org/0000-0003-1886-9145","observed_orcids":["https://orcid.org/0000-0003-1886-9145"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michele W.L. Teng","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056768522","display_name":"Oliver Kepp","orcid":"https://orcid.org/0000-0002-6081-9558","observed_orcids":["https://orcid.org/0000-0002-6081-9558"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oliver Kepp","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100604312","display_name":"Yidan Wang","orcid":"https://orcid.org/0009-0001-5890-0672","observed_orcids":["https://orcid.org/0009-0001-5890-0672"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yidan Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065469646","display_name":"Antonella Sistigu","orcid":"https://orcid.org/0000-0002-2528-1238","observed_orcids":["https://orcid.org/0000-0002-2528-1238"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antonella Sistigu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073445890","display_name":"Joachim Ludwig Schultze","orcid":"https://orcid.org/0000-0003-2812-9853","observed_orcids":["https://orcid.org/0000-0003-2812-9853"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joachim L. Schultze","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063687089","display_name":"Gautier Stoll","orcid":"https://orcid.org/0000-0002-0862-4139","observed_orcids":["https://orcid.org/0000-0002-0862-4139"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gautier Stoll","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071827163","display_name":"Lorenzo Galluzzi","orcid":"https://orcid.org/0000-0003-2257-8500","observed_orcids":["https://orcid.org/0000-0003-2257-8500"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lorenzo Galluzzi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074612242","display_name":"Laurence Zitvogel","orcid":"https://orcid.org/0000-0003-1596-0998","observed_orcids":["https://orcid.org/0000-0003-1596-0998"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laurence Zitvogel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061575707","display_name":"Mark John Smyth","orcid":"https://orcid.org/0000-0001-7098-7240","observed_orcids":["https://orcid.org/0000-0001-7098-7240"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark J. Smyth","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5075296559","display_name":"Guido Kroemer","orcid":"https://orcid.org/0000-0002-9334-4405","observed_orcids":["https://orcid.org/0000-0002-9334-4405"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guido Kroemer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.7056000232696533,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.7056000232696533,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.2728999853134155,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.0071000000461936,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ccl2-ccr2-signaling","display_name":"CCL2/CCR2 signaling","score":0.9330000281333923},{"id":"https://openalex.org/keywords/dendritic-cells","display_name":"dendritic cells","score":0.828000009059906},{"id":"https://openalex.org/keywords/antigen-presenting-cells","display_name":"antigen-presenting cells","score":0.8949999809265137},{"id":"https://openalex.org/keywords/anthracycline-based-chemotherapy","display_name":"anthracycline chemotherapy","score":0.8140000104904175},{"id":"https://openalex.org/keywords/immunogenic-chemotherapy","display_name":"immunogenic chemotherapy","score":0.9309999942779541},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.5649999976158142},{"id":"https://openalex.org/keywords/chemokine-recruitment","display_name":"chemokine recruitment","score":0.6570000052452087},{"id":"https://openalex.org/keywords/ccr2-deficient-mice","display_name":"CCR2-deficient mice","score":0.9570000171661377},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.6869999766349792},{"id":"https://openalex.org/keywords/tumor-antigen-specific-t-cells","display_name":"tumor antigen-specific T cells","score":0.6240000128746033}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6534554362297058},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5364696383476257},{"id":"https://openalex.org/C2779919695","wikidata":"https://www.wikidata.org/wiki/Q4201963","display_name":"CD11c","level":4,"score":0.520712673664093},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5061928629875183},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.47290027141571045},{"id":"https://openalex.org/C101666144","wikidata":"https://www.wikidata.org/wiki/Q2587862","display_name":"CCL2","level":4,"score":0.4361831843852997},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4273066520690918},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.42639926075935364},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37425696849823},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34878551959991455},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.32501697540283203},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32311558723449707},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15351399779319763},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/0008-5472.c.6505829","doi":"https://doi.org/10.1158/0008-5472.c.6505829","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6505829","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/0008-5472.c.6505829.v1","doi":"https://doi.org/10.1158/0008-5472.c.6505829.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6505829.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6505829","doi":"https://doi.org/10.1158/0008-5472.c.6505829","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6505829","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1990788258","https://openalex.org/W2038218697","https://openalex.org/W4231112787","https://openalex.org/W1989738819","https://openalex.org/W2011224241","https://openalex.org/W1574653831","https://openalex.org/W4415554278","https://openalex.org/W2140996651","https://openalex.org/W2127316031","https://openalex.org/W2223604696"],"abstract_inverted_index":{"Abstract":[0],"The":[1],"therapeutic":[2,123,140],"efficacy":[3],"of":[4,13,31,60,85,134],"anthracyclines":[5,80],"relies,":[6],"at":[7],"least":[8],"partially,":[9],"on":[10],"the":[11,29,40,58,86,132,135],"induction":[12],"a":[14,90],"dendritic":[15,34,103],"cell\u2013":[16],"and":[17],"T-lymphocyte\u2013dependent":[18],"anticancer":[19,141],"immune":[20,142],"response.":[21],"Here,":[22],"we":[23,74],"show":[24],"that":[25,76],"anthracycline-based":[26,126],"chemotherapy":[27],"promotes":[28],"recruitment":[30],"functional":[32],"CD11b+CD11c+Ly6ChighLy6G\u2212MHCII+":[33],"cell\u2013like":[35,104],"antigen-presenting":[36],"cells":[37,64],"(APC)":[38],"into":[39,45],"tumor":[41,61],"bed,":[42],"but":[43],"not":[44],"lymphoid":[46],"organs.":[47],"Accordingly,":[48],"draining":[49],"lymph":[50],"nodes":[51],"turned":[52],"out":[53],"to":[54,101,108,125],"be":[55],"dispensable":[56],"for":[57,139],"proliferation":[59],"antigen\u2013specific":[62],"T":[63],"within":[65],"neoplastic":[66],"lesions":[67],"as":[68,94,144],"induced":[69],"by":[70,146],"anthracyclines.":[71],"In":[72],"addition,":[73],"found":[75],"tumors":[77],"treated":[78],"with":[79],"manifest":[81],"increased":[82],"expression":[83],"levels":[84],"chemokine":[87],"Ccl2.":[88],"Such":[89],"response":[91,107],"is":[92],"important":[93],"neoplasms":[95],"growing":[96],"in":[97,106,113],"Ccl2\u2212/\u2212":[98],"mice":[99,114],"failed":[100],"accumulate":[102],"APCs":[105],"chemotherapy.":[109,127,148],"Moreover,":[110],"cancers":[111],"developing":[112],"lacking":[115],"Ccl2":[116],"or":[117],"its":[118],"receptor":[119],"(Ccr2)":[120],"exhibited":[121],"suboptimal":[122],"responses":[124,143],"Altogether,":[128],"our":[129],"results":[130],"underscore":[131],"importance":[133],"CCL2/CCR2":[136],"signaling":[137],"axis":[138],"elicited":[145],"immunogenic":[147],"Cancer":[149],"Res;":[150],"74(2);":[151],"436\u201345.":[152],"\u00a92013":[153],"AACR.":[154]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}